Cadila’s Commitment Stories – October 2020
2nd Nov, 2020
One of the bright rays of light emerging from the pandemic has been the immense display of pro-social and humanitarian behavior. For Cadila Pharmaceuticals, care and compassion are the key drivers for emerging triumphant amidst all crisis– be it through designing affordable and innovative healthcare products or services, nurturing young leaders or standing beside people in times of need.
We launched new products like cardiovascular drug Tikacad to provide quality care and affordable medication to heart patients. Our experts spoke about the role of block chain in the Pharma Revolution to bring about smoother delivery of healthcare and services. On World Psoriasis Day, on 29th October we dedicated ourselves in spreading awareness about Psoriasis through facts and myths and highlighting the role of Biosimilar as a cost-effective option for the treatment of Psoriasis. Our leaders shed light on how the pharma industry has to evolve to adapt itself to the changing consumer beliefs and behavior in the new normal. October also marked the launch of the eighth chapter of iamicon – one of the largest innovation conclaves bringing top healthcare professionals to one platform to discuss latest innovations of the world. This month, we welcomed our youngest leaders and as they embark on their professional journey, our senior leadership shared guidance and tips for the same. Keeping the message of compassion alive, Cadila Pharma and Akshya Patra foundation continued with distribution of essential food items to the students who have been missing mid-day meals during lockdown.
Healthy people and a healthy world are both strengthened immeasurably by having compassion at the heart of health. Read about how the care continues at Cadila always.
Cadila Pharmaceuticals launches Tikacad®
Cadila Pharmaceuticals launches Tikacad® in India, an antiplatelet drug containing Ticagrelor, a P2Y12 platelet inhibitor indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI).
Blockchain in Supply Chain of Pharmaceutical Industry – Key element for Industry 4.0
With the current pandemic, industries around the world are experiencing a revolution. One such revolution that we are looking at, in the pharma industry, is the application of Blockchain in supply chain. We asked Srikant Prakash, from Active Pharmaceutical Ingredients Business on the evolution of blockchain in supply chain in pharma industry.
Fight Psoriasis Through Awareness About Novel Treatment Options
Psoriasis can be managed by using proper medications and maintaining a healthy lifestyle. We at Cadila Pharmaceuticals are working towards redefining the dermal treatment paradigm through biosimilars like Adalimumab.
Adapting to the changing consumer beliefs, behaviours and habits in the new normal
Every marketer across the globe is grappling with this change and working to focusing on new ways to delight them. Mr. Aditya Vikram Singh, AVP -Sales and Marketing shares his views on bringing customer delight amidst the accelerated digital transformation and the new normal.
Dear Young Leaders, A Great Journey Awaits You!
As the young leaders start their careers and face new challenges of corporate life, our leaders Mr. A. Thiru, Mr. Suresh Gupta, Dr Manjul Joshipura, Mr. Mahidhwaj Sisodia and Mr. V. K. Singh share guidance on what they should focus on as budding professionals.
iamicon 2020 – Journey through the years
This year, iamicon has gone virtual and broken all physical barriers. iamicon 2020 is going to be grander as we invite some of the best national and international speakers to talk about innovations in different therapies such as cardiology, rheumatology, pulmonology, gastroenterology, etc.
Cadila Pharma, Akshaya Patra foundation continue to help families of students through distribution of essential kits
The Akshaya Patra foundation and Cadila Pharmaceuticals have been sponsoring the unlimited mid-day meals for 10,863 students studying in 38 Government Primary Schools of Ahmedabad and Gandhinagar districts. Cadila Pharma and Akshaya Patra foundation are trying to help as many students as they can, in these trying times.
